|Articles|June 21, 2023
Common approaches to bioanalysis of oligonucleotides
Author(s) Pyxant
The significance of oligonucleotides (OGNTs) in drug development is increasing rapidly, as they offer promising and life-changing treatments that can improve patients' lives. Within bioanalysis, there are five main approaches to consider, each of which has its advantages and disadvantages.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
3
Halo Pharma Becomes Dedicated North American Drug Product CDMO
4
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
5